Genetic disorder characterized by high cholesterol levels
Medical condition
Familial hypercholesterolemia
Other names
Familial hypercholesterolaemia
Xanthelasma palpebrarum, yellowish patches consisting of cholesterol deposits above the eyelids. These are more common in people with FH.
Specialty
Endocrinology
Familial hypercholesterolemia (FH) is a genetic disorder characterized by high cholesterol levels, specifically very high levels of low-density lipoprotein cholesterol (LDL cholesterol), in the blood and early cardiovascular diseases. The most common mutations diminish the number of functional LDL receptors in the liver or produce abnormal LDL receptors that never go to the cell surface to function properly (abnormal trafficking).[citation needed] Since the underlying body biochemistry is slightly different in individuals with FH, their high cholesterol levels are less responsive to the kinds of cholesterol control methods which are usually more effective in people without FH (such as dietary modification and statin tablets). Nevertheless, treatment (including higher statin doses) is usually effective.
FH is classified as a type 2 familial dyslipidemia.[1] There are five types of familial dyslipidemia (not including subtypes), and each are classified from both the altered lipid profile and by the genetic abnormality. For example, high LDL (often due to LDL receptor defect) is type 2. Others include defects in chylomicron metabolism, triglyceride metabolism, and metabolism of other cholesterol-containing particles, such as VLDL and IDL.
About 1 in 100 to 200 people have mutations in the LDLR gene that encodes the LDL receptor protein, which normally removes LDL from the circulation, or apolipoprotein B (ApoB), which is the part of LDL that binds with the receptor; mutations in other genes are rare but important to know, including gain-of-function mutations in PCSK9, the molecular "scissor" of LDL receptors, resulting in less LDLR available. PCSK9 mutations cause less than 5% of cases of FH according to most epidemiologic studies.[2] People who have one abnormal copy (are heterozygous) of the LDLR gene may develop cardiovascular disease prematurely at the age of 30 to 40. Having two abnormal copies (being homozygous) may cause severe cardiovascular disease in childhood. Heterozygous FH is a common genetic disorder, inherited in an autosomal dominant pattern, occurring in 1:250 people in most countries;[3] homozygous FH is much rarer, occurring in 1 in 300,000 people.[citation needed]
Heterozygous FH is normally treated with statins, bile acid sequestrants, or other lipid-lowering agents that lower cholesterol levels. New cases are generally offered genetic counseling. Homozygous FH often does not respond to medical therapy and may require other treatments, including LDL apheresis (removal of LDL in a method similar to dialysis) and occasionally liver transplantation.[4]
^Goldberg AC, Hopkins PN, Toth PP, Ballantyne CM, Rader DJ, Robinson JG, Daniels SR, Gidding SS, de Ferranti SD, Ito MK, McGowan MP, Moriarty PM, Cromwell WC, Ross JL, Ziajka PE, National Lipid Association Expert Panel on Familial H (June 2011). "Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia". Journal of Clinical Lipidology. 5 (3 Suppl): S1–8. doi:10.1016/j.jacl.2011.04.003. PMID 21600525.
^Akioyamen LE, Genest J, Shan SD, Reel RL, Albaum JM, Chu A, et al. (2017). "Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis". BMJ Open. 7 (9): e016461. doi:10.1136/bmjopen-2017-016461. PMC 5588988. PMID 28864697.{{cite journal}}: CS1 maint: multiple names: authors list (link)
^Cite error: The named reference Rader2003 was invoked but never defined (see the help page).
and 29 Related for: Familial hypercholesterolemia information
Familialhypercholesterolemia (FH) is a genetic disorder characterized by high cholesterol levels, specifically very high levels of low-density lipoprotein...
inherited (genetic) diseases (such as LDL receptor mutations in familialhypercholesterolemia), or the presence of other diseases such as type 2 diabetes...
are effective at reducing cholesterol levels in those with familialhypercholesterolemia. Their long term safety is, however, unclear. Some recommend...
medicine went to two researchers for their work related to familialhypercholesterolemia, which causes large and rapid increases in cholesterol levels...
Making Guidance of Pediatric FamilialHypercholesterolemia (2018-06-01). "Guidance for Pediatric FamilialHypercholesterolemia 2017". Journal of Atherosclerosis...
Kynamro) was approved by the FDA for the treatment of homozygous familialhypercholesterolemia. Inotersen received FDA approval for the treatment of hereditary...
dyslipidemia and the prevention of cardiovascular disease: Hypercholesterolemia (heterozygous familial and nonfamilial) and mixed dyslipidemia (Fredrickson...
cardiovascular disease (ASCVD), ASCVD risk-equivalents, and heterozygous familialhypercholesterolemia (HeFH). It is a small interfering RNA (siRNA) that acts as an...
heterozygous hypercholesterolemia, familial hypertriglyceridemia, combined hyperlipidemia, and HDL-C metabolism disorders. In familialhypercholesterolemia, a mutation...
medication used as a lipid-lowering agent for the treatment of familialhypercholesterolemia, developed by Aegerion Pharmaceuticals. It has been tested in...
diseases produced by mutations of the LDL receptor, such as familialhypercholesterolemia. Treatment may include, niacin or statin or ezetimibe.: 534 ...
apolipoprotein C-III and lower its concentrations to treat people with familialhypercholesterolemia and hypertriglyceridemia. Spagnuolo, Catherine M; Hegele, Robert...
by the FDA for treatment of hypercholesterolemia, notably the genetic condition heterozygous familialhypercholesterolemia which causes high cholesterol...
hyperlipidemia, in combination with fenofibrate Homozygous familialhypercholesterolemia, in combination with specific statins Homozygous sitosterolemia...
(INN; trade name Kynamro) is a drug used to treat homozygous familialhypercholesterolemia and is administered by subcutaneous injection. There is a serious...
screening can be valuable to detect genetic diseases such as familialhypercholesterolemia that can be lethal if not treated early.[citation needed] Traditionally...
illustrate the disruptions that occur due to these inefficiencies. Familialhypercholesterolemia: this disorder is characterized by the absence of functional...
the subject of debate. One variation, which is implicated in familialhypercholesterolemia, has been dated to the 14th century, corresponding to the establishment...
Watch Industry FH Futura International Airways (IATA code) Familialhypercholesterolemia, a genetic disorder Factor H, a complement control protein Family...
the subject of debate. One variation, which is implicated in familialhypercholesterolemia, has been dated to the 14th century, corresponding to the establishment...
tendons of the hands, feet, and heel.: 531 Also associated with familialhypercholesterolemia (FH). Eruptive xanthoma (ILDS E78.220) is clinically characterized...
identification of LDL-R and its relation to cholesterol metabolism and familialhypercholesterolemia. Disruption of LDL-R can lead to higher LDL-cholesterol as well...
apheresis – removal of low density lipoprotein in patients with familialhypercholesterolemia. Lipoprotein(a) (Lp(a) apheresis Photopheresis – used to treat...
is found in non-Jewish groups. A few diseases are unique to this group; familial dysautonomia, for example, is almost unknown in other peoples. Tay–Sachs...
(PDF) from the original on 2008-11-18. "OMIM Entry #144010 – HYPERCHOLESTEROLEMIA, FAMILIAL, 2; FCHL2". omim.org. Archived from the original on 2021-03-09...
conotruncal defects, left ventricular outflow tract defects) Familialhypercholesterolemia Family history of unexplained sudden death Guidelines on cardiovascular...
Achilles tendon of people with lipid metabolism disorders such as familialhypercholesterolemia. The Achilles tendon is often tested as part of a neurological...
low-density lipoprotein cholesterol (LDL) in patients with homozygous familialhypercholesterolemia (HoFH), which is a rare autosomal dominant genetic condition...
Global Information